CLINICAL TRIALS PROFILE FOR TECHNETIUM TC-99M SULFUR COLLOID KIT

All Clinical Trials for TECHNETIUM TC-99M SULFUR COLLOID KIT

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003654 ↗	Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer	Terminated	UNICANCER	N/A	1997-09-01	RATIONALE: Diagnostic procedures, such as blue dye or imaging to identify sentinel lymph nodes, may improve the ability to detect the extent of disease and help plan effective surgery for removing breast tumors. PURPOSE: Diagnostic trial to study the effectiveness of blue dye and an imaging procedure to identify the sentinel lymph node under the arm in women with stage I or stage II breast cancer.
NCT00012168 ↗	Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat	Completed	National Cancer Institute (NCI)	N/A	1999-05-01	RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node metastases in the neck in patients who have mouth or throat cancer.
NCT00012168 ↗	Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat	Completed	New York University School of Medicine	N/A	1999-05-01	RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node metastases in the neck in patients who have mouth or throat cancer.
NCT00012168 ↗	Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat	Completed	NYU Langone Health	N/A	1999-05-01	RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck. PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node metastases in the neck in patients who have mouth or throat cancer.
NCT00052676 ↗	Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer	Completed	Centre Paul Strauss	N/A	2002-10-01	RATIONALE: It is not yet known whether injecting technetium Tc 99m sulfur colloid and blue dye near the tumor is more effective than injecting them near the nipple in identifying sentinel lymph nodes in patients with stage I or stage II breast cancer. PURPOSE: Randomized diagnostic trial to compare the effectiveness of injecting technetium Tc 99m sulfur colloid and blue dye near the tumor with that of injections around the nipple in detecting sentinel lymph nodes in patients who have stage I or stage II breast cancer.
NCT00070317 ↗	Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer	Terminated	National Cancer Institute (NCI)	N/A	2004-06-01	This clinical trial is studying how well lymph node mapping and sentinel lymph node identification work in finding lymph node metastases in patients with stage IB1 cervical cancer. Diagnostic procedures, such as lymph node mapping and sentinel lymph node identification, performed before and during surgery, may improve the ability to detect lymph node metastases in patients who have cervical cancer.
NCT00070317 ↗	Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer	Terminated	Gynecologic Oncology Group	N/A	2004-06-01	This clinical trial is studying how well lymph node mapping and sentinel lymph node identification work in finding lymph node metastases in patients with stage IB1 cervical cancer. Diagnostic procedures, such as lymph node mapping and sentinel lymph node identification, performed before and during surgery, may improve the ability to detect lymph node metastases in patients who have cervical cancer.

Clinical Trial Conditions for TECHNETIUM TC-99M SULFUR COLLOID KIT

Condition Name

Condition Name for TECHNETIUM TC-99M SULFUR COLLOID KIT
Intervention	Trials
Breast Cancer	6
Stage II Breast Cancer	2
Cystic Fibrosis	2
Stage I Breast Cancer	1

Condition MeSH

Condition MeSH for TECHNETIUM TC-99M SULFUR COLLOID KIT
Intervention	Trials
Breast Neoplasms	8
Carcinoma	2
Melanoma	2
Fibrosis	2

Clinical Trial Locations for TECHNETIUM TC-99M SULFUR COLLOID KIT

Trials by Country

Trials by Country for TECHNETIUM TC-99M SULFUR COLLOID KIT
Location	Trials
United States	17
France	2

Trials by US State

Trials by US State for TECHNETIUM TC-99M SULFUR COLLOID KIT
Location	Trials
California	3
Pennsylvania	3
Texas	2
New York	2
Wisconsin	1

Clinical Trial Progress for TECHNETIUM TC-99M SULFUR COLLOID KIT

Clinical Trial Phase

Clinical Trial Phase for TECHNETIUM TC-99M SULFUR COLLOID KIT
Clinical Trial Phase	Trials
Phase 2	2
Phase 1/Phase 2	1
Phase 1	2

Clinical Trial Status

Clinical Trial Status for TECHNETIUM TC-99M SULFUR COLLOID KIT
Clinical Trial Phase	Trials
Completed	12
Terminated	3
Recruiting	3

Clinical Trial Sponsors for TECHNETIUM TC-99M SULFUR COLLOID KIT

Sponsor Name

Sponsor Name for TECHNETIUM TC-99M SULFUR COLLOID KIT
Sponsor	Trials
National Cancer Institute (NCI)	9
M.D. Anderson Cancer Center	2
University of Pittsburgh	2

Sponsor Type

Sponsor Type for TECHNETIUM TC-99M SULFUR COLLOID KIT
Sponsor	Trials
Other	25
NIH	12
Industry	3